Genzyme diarrhea drug fails large test
Tolevamer marks 2d disappointment for firm in two days
An experimental antidiarrhea drug made by Genzyme Corp. failed its first large test in humans, the company said yesterday, the second disappointment for the Cambridge biotechnology giant in two days. (Full article: 484 words)
This article is available in our archives:
Globe Subscribers
FREE for subscribers
Subscribers to the Boston Globe get unlimited access to our archives.
Not a subscriber?
Non-Subscribers
Purchase an electronic copy of the full article. Learn More
- $4.95 1 article
- $9.95 4 articles
- $25.95 Monthly
